Industry-Supported Symposium
Gregg Silverman, MD
NYU Grossman School of Medicine
New York, New York, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Julie Paik, MD, MHS
Johns Hopkins University
Baltimore, Maryland, United States
Disclosure information not submitted.
Please note: This session is not eligible for CME Credits through ACR.
This session will not be recorded for on-demand.
This symposium explores the role of autoantibodies in the pathophysiology of autoimmune diseases, with a focus on myositis and Sjögren’s disease. Through a hypothetical patient case, faculty will highlight the complexity and delays often seen in diagnosis. The session will also introduce FcRn as a novel therapeutic target, outlining its role in IgG regulation and the rationale for FcRn blockade in these conditions. Enrolling clinical trials will be discussed to illustrate emerging therapeutic strategies. Developed and offered by MedForce and supported by Argenx. Not an official program of the ACR.
